Kalpak Gude of Project Kuiper talks about cooperation on satellite orbits to keep space safe and usable for future ...
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab (Leqembi) has been approved for once every four weeks intravenous (IV) maintenance dosing for the ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...
One often-repeated example illustrates the mind-boggling potential of quantum computing: A machine with 300 quantum bits ...
Overall, core resilience has become the defining capability for PayTechs in a world of constant digital demands. Modern platforms transform continuity from an afterthought into a competitive strength ...
Main outcome measures The main outcome was the type of injuries observed by international healthcare workers during the ...
In this important work, the authors present a new transformer-based neural network designed to isolate and quantify higher-order epistasis in protein sequences. They provide solid evidence that higher ...
With 400.05 BNB ($402,050) locked in an completely ownerless smart contract, BNBCapital presents a fascinating case study in ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
Bacteria are constantly moving with the help of motility organs called flagella or pili to colonize new niches. Also, ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher ...
BACKGROUND: PYGM (muscle glycogen phosphorylase), the rate-limiting enzyme in glycogenolysis, plays an indispensable role in maintaining cardiac energy metabolism. However, the role of PYGM in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback